Psychiatrist-led treatment of hepatitis C (HCV) at an opioid agonist treatment (OAT) clinic in Stockholm - enhancing the HCV treatment care cascade

INTRODUCTION: People who inject drugs (PWID) and opioid agonist treatment (OAT) patients have an increased hepatitis C (HCV) prevalence. Studies among these populations show promising HCV treatment results, which is essential to reach the WHO goal of eliminating HCV as a major public health threat b...

Descripción completa

Detalles Bibliográficos
Autores principales: Kåberg, M., Klasa, P.-E., Nordin, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563151/
http://dx.doi.org/10.1192/j.eurpsy.2022.468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563151/
http://dx.doi.org/10.1192/j.eurpsy.2022.468

Ejemplares similares